Systemic mGIPR-Ab/GLP-1 activates brain regions involved in food intake control To determine whether mGIPR-Ab/GLP-1 peptideantibody conjugates access brain regions expressing GIPR and GLP-1R, IgG1 immunostaining was used to visualize mGIPR-Ab/P3 biodistribution in the brain 4 h after IP administration
Antibiotics Wegovy can interact with certain antibiotics, which are used to treat infections caused by bacteria
Wegovy Wegovy contains semaglutide and was initially approved by the FDA for chronic weight loss in adults and children aged 12 and older with obesity or weight-related health conditions
Visual changes to the powder are often the first indicator of a problem
Endocrinology 137:23832388 Nauck MA, Heimesaat MM, rskov C, Holst JJ, Ebert R, Creutzfeldt W (1993) Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus